The proportions of patients who discontinued study drug after randomization were 21.3% for the ZEPBOUND-treated group and 30.5% for the placebo-treated group
The biggest concern about these unregulated peptides is the lack of adequate human clinical evidence for the uses they are being marketed for, says Rita Jew, PharmD, president at the Institute for Safe Medication Practices in San Francisco
The medicinal form depends on how well it is absorbed in the body and factors such as age, genetics, and the condition of the digestive system
Researchers discovered its powerful protective and healing effects, particularly in the gastrointestinal (GI) tract
For a comprehensive assessment of cardiometabolic risk alongside these performance markers, the Heart Vitality Panel adds important context, particularly in older patients for whom metabolic and cardiovascular risk tracking should proceed in parallel